PubMatic’s (NASDAQ:PUBM) Q2 CY2026: Strong Sales, Stock Jumps 20.8%

PubMatic (NASDAQ:PUBM) reported Q2 CY2026 revenue of $78.59 million, up 10.5% year on year and 13.7% above Wall Street estimates, according to the company. Non-GAAP EPS was $0.12. Next-quarter revenue guidance was $76 million at the midpoint, 7.3% above analyst expectations. The stock rose 20.8% to $16.28 after results.

Original reporting
Published Aug 6, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 10:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
PubMatic’s (NASDAQ:PUBM) Q2 CY2026: Strong Sales, Stock Jumps 20.8% — source image
Decision brief

The 30-second read

$PUBMBullishMed
01

Why it matters

The newest actionable inputs are the Q2 revenue beat ($78.59M, +10.5% YoY), next-quarter revenue guidance ($76M midpoint) described as above consensus, and the non-GAAP EPS of $0.12. The article also adds a cautionary efficiency metric, negative CAC payback, and notes longer-term growth deceleration.

02

Market read

Traders can reassess near-term expectations after the reported revenue beat and upside guidance, while monitoring whether efficiency concerns (negative CAC payback) persist.

03

What to watch

The article cites decelerating revenue growth trends and negative CAC payback, which could outweigh the single-quarter beat if investors focus on sustainable unit economics.

Relevance 8/10Novelty 7/10Timing: after-hours/next-session positioning following Q2 results and guidance

Background

PubMatic is an ad-tech platform monetizing publisher inventory across the open internet; the article frames its Q2 performance and next-quarter outlook.

Company-level read

Ticker impact

$PUBMBullishMedium confidence
Context

PubMatic reported Q2 CY2026 revenue of $78.59M (+10.5% YoY) and guided next-quarter revenue to $76M midpoint, above expectations.

Expected impact

Near-term upside bias versus consensus, with elevated risk of profit-taking given the article’s concerns about demand slowdown and CAC efficiency.

Evidence & confidence

The text provides concrete Q2 results, explicit next-quarter guidance versus analyst expectations, and a same-session stock jump of 20.8%, which together justify a momentum-positive read while the negative CAC payback and decelerating growth temper conviction.

Market effects

Signals continued demand for open-internet ad monetization platforms, but highlights competitive pressure via negative CAC payback.

Primarily US small/mid-cap ad-tech sentiment; limited direct regional spillover described.

No explicit global regulatory or macro drivers mentioned; impact is company-specific to ad-tech demand and monetization efficiency.

Counterpoint

The guidance beat may reflect timing or one-off factors, while negative CAC payback and slowing growth suggest the quality of demand could be deteriorating.

Key entities

  • PubMatic

    Reported Q2 CY2026 revenue and provided next-quarter revenue guidance; stock jumped 20.8% after results per the article.

Related articles

$TEAMHighAI 8/10

Five earnings winners lead Friday’s premarket surge

Atlassian (TEAM) surged about 31% premarket after fiscal Q4 adjusted EPS of $1.87 vs $1.50 consensus and revenue of $1.77B vs $1.66B, with cloud revenue up 31% and remaining performance obligations up 44%, plus a GAAP operating profit. Other premarket gainers: Doximity (+66%), Cloudflare (+16.2%), PubMatic (+30.4%), FIGS (+28-30%).

$DOCSHighAI 8/10

Doximity, Cloudflare and Atlassian surge premarket

U.S. stock index futures edged higher ahead of the monthly jobs report, with investors watching the Federal Reserve rate outlook. Premarket movers included Doximity (+66%) on fiscal Q1 beats and raised targets, Atlassian (+31%) on a Q4 earnings beat, and Cloudflare (+16%) after raising 2026 revenue guidance. The Trade Desk fell more than 27% on weak outlook.

$PUBMHighAI 9/10

Why is PubMatic stock up 30% today?

PubMatic shares rose about 30% in pre-open after the company reported Q2 2026 results above expectations. Revenue was $78.6M, up 11% YoY. Adjusted EPS was $0.12 versus a consensus loss of $0.23, and adjusted EBITDA rose 38% to $19.6M with a 25% margin. Q3 revenue guidance was $75–$77M. Multiple analyst upgrades and buybacks were cited.

$PUBMMed

PubMatic, Inc. (PUBM): Results of Operations and Financial Condition

PubMatic, Inc. (PUBM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q226pressrelease.htm EX-99.1 Document EXHIBIT 99.1 PubMatic Announces Second Quarter 2026 Financial Results Delivered revenue and adjusted EBITDA well ahead of guidance; AI customer adoption more than doubled sequentially, delivering 80+ agentic campaigns and 4,000+ AI-

$PUBMMed

Magnite CEO warns of far fewer SSPs as PubMatic faces a $70m quarter

Magnite CEO Michael Barrett said sell-side platform (SSP) consolidation is likely, with fewer, more technically sophisticated SSPs surviving, and that agentic ad spend forecasts for 2027 top around $600m to $700m, still in discovery. The article contrasts this with PubMatic’s agentic product launches and Q1 2026 results: $62.6m revenue, $12.5m GAAP net loss, $2.6m adjusted EBITDA, and emerging revenues up 80% to $8.8m. PubMatic reports Aug 6.

$DRIMedAI 8/10

DRI Healthcare Reports Second Quarter 2026 Results and New Board Appointment

DRI Healthcare Trust (TSX: DHT.UN, DHT.U) reported Q2 2026 results for the quarter ended June 30, 2026: total income $50.1M, total cash receipts $46.5M, and adjusted EBITDA $42.6M. It repurchased 89,513 units at $11.65 and paid a $0.11/unit distribution. After quarter-end, it exercised a put option on Ekterly for about $178M and received FDA approval for Lumvoa (veligrotug), triggering $75M milestone payments.